IntuitionLabs
AI and MCP integration with Suvoda IRT and RTSM for clinical trial operations in pharmaceutical sponsors and CROs

AI & MCP Integration for Suvoda

Compliance-aware AI agents, drug supply forecasting, protocol amendment impact analysis, and operational analytics co-pilots — all layered on top of your validated Suvoda IRT, RTSM, eConsent, and eCOA environment.

What AI on Suvoda Looks Like

Three complementary layers of AI capability deployed against your existing Suvoda study builds — under audit, with humans in the loop, and aligned with GCP and global GxP expectations.

Layer 1
Supply Forecasting
AI-enhanced site, depot, and country-level kit forecasting with confidence intervals — reducing both stockouts and overage across active studies through continuous retraining on Suvoda dispensation data.
Discuss forecasting
Layer 2
Amendment Analysis
AI reads redlined protocols and produces structured Suvoda study-build change requests with effort estimates and risk flags — accelerating amendment delivery without compromising change control.
Discuss amendments
Layer 3
Operational Co-Pilots
Natural-language Q&A over randomization, dispensation, and visit data with cited answers and full audit trails of prompts, model versions, and human acknowledgements.
Discuss co-pilots

Connected via Model Context Protocol

We expose Suvoda to AI clients through a custom MCP server built over the documented APIs. MCP is an open standard for connecting AI assistants to enterprise data; using it means your investment is portable across Claude, GPT, Gemini, and any future MCP-compatible client rather than locked to one vendor. The MCP server enforces your role-based access policies, masks unblinded fields where appropriate, and writes every tool call to an immutable audit log.

Suvoda connected to AI assistants through Model Context Protocol with blinding-aware access enforcement

Compliance-Aware by Design

AI never bypasses Suvoda's validated controls or compromises trial integrity. Every artefact an AI agent contributes to passes through human review and electronic signature where required under 21 CFR Part 11 and ICH E6(R3). Prompts, retrieval sources, model identifiers, and responses are logged to a tamper-evident store that mirrors the depth of evidence inspectors expect. This pattern aligns with the FDA draft guidance on AI in drug development.

Compliance-aware AI integration with Suvoda showing audit trail, electronic signature, and blinding-aware prompt logging

Hosted Where Your Data Belongs

We deploy AI in whichever topology fits your data residency: tenanted endpoints on AWS Bedrock or Azure OpenAI, dedicated capacity on GCP Vertex, or open-weight models running entirely on-premise. Outside-the-firewall calls go through the IntuitionLabs AI proxy with no model-provider training on customer data and full prompt-level audit. We document the data flow diagrams, threat models, and DPIA-equivalent assessments so security and quality teams can sign off without hand-waving.

Flexible AI deployment topology for Suvoda including cloud, dedicated tenant, and on-premise options

High-Value AI Use Cases on Suvoda

Six use cases where AI integration with Suvoda generates measurable returns — drawn directly from sponsor and CRO clinical operations.

Drug Supply Forecasting

AI-enhanced site, depot, and country-level kit forecasting using Suvoda dispensation history, enrollment curves, and expiry data — reducing both stockouts and overage with explicit confidence intervals.

Discuss forecasting

Protocol Amendment Analysis

AI reads redlined protocols and produces structured Suvoda change requests mapped to existing configuration — randomization schema, kit logic, visit schedules — with effort estimates and risk flags for human review.

Discuss amendments

Operational Analytics Co-Pilot

Natural-language Q&A over randomization, IP, and visit data — "which sites are at stockout risk?", "show enrollment-vs-forecast variance by region" — with cited answers and full audit trails.

Discuss analytics

Study-Build Drafting

AI drafts URS sections, randomization schema documentation, and configuration specs from approved protocols. Validation teams review and approve; the AI does not bypass change control.

Discuss drafting

Expiry & Wastage Optimization

AI models kit expiry against forecasted dispensation across the depot network to surface re-allocation opportunities — keeping more kits in trial use and reducing destruction cost without risking stockouts.

Discuss expiry

Cross-Study Intelligence

When Suvoda data is unified with Snowflake or Databricks alongside EDC and CTMS data, AI co-pilots answer cross-study questions on enrollment performance, site productivity, and supply patterns across the portfolio.

Discuss cross-study

What Makes IntuitionLabs Different on AI + Suvoda

Plenty of consultancies offer AI services. Few combine the regulated-systems validation chops with the AI engineering depth and clinical-operations fluency that sponsors and CROs actually need on a platform like Suvoda.

Compliance-First AI

21 CFR Part 11, EU Annex 11, GAMP 5, ICH E6(R3), and ALCOA+ — all baked into our AI deployment patterns by default.

MCP-Native Engineering

We build MCP servers as first-class artefacts so your AI investment travels across Claude, GPT, and future clients without rework.

Clinical-Operations Depth

IRT, RTSM, eConsent, eCOA, and clinical-supply workflows are not learning curves for us — they are the work we do every week.

The AI Stack We Deploy

🔌

MCP Server

Custom Model Context Protocol server over Suvoda APIs. Enforces RBAC, masks unblinded fields where required, and writes every tool invocation to an immutable audit log so security and quality teams can review what AI clients actually accessed.

🔍

Forecasting Engine

AI-enhanced supply forecasting layer that ingests Suvoda dispensation history, enrollment curves, kit expiry, and depot lead times to produce site, depot, and country-level forecasts with explicit confidence intervals.

🛰️

AI Proxy & Routing

All model calls flow through the IntuitionLabs AI proxy with full request logging, prompt versioning, and tiered routing — frontier models for complex queries, smaller cheaper models for routine tasks, on-prem models where data residency demands it.

✅

Approval Gateway

Every AI-drafted change request or analytical insight passes through a human review and electronic signature gate before becoming part of the GxP record or feeding a production decision. The audit trail captures the AI rationale, sources, and human edits.

📏

Evaluation Harness

Continuous evaluation against benchmark prompts and known-good outputs. Detects model drift on every provider release, flags regressions, and feeds the periodic review evidence pack required by GAMP 5 and FDA Computer Software Assurance.

📊

Telemetry & Cost

Per-study and per-use-case telemetry on AI usage, token spend, retrieval cache hit rate, forecast accuracy, and approval rates. Makes the cost-per-study of AI explicit so the programme demonstrably trends toward better outcomes per dollar.

Frequently Asked Questions

In our usage, AI integration means connecting modern large language models — Claude, GPT, Gemini — and purpose-built statistical models to your Suvoda environment so clinical operations teams can forecast supply more accurately, analyse protocol amendment impact, and ask natural-language questions over randomization and IP data. Connectivity uses Suvoda's APIs or — where appropriate — a Model Context Protocol (MCP) server we build over your study data so any MCP-compatible AI client can interact safely. All integrations honour your role-based access controls, audit trails, and blinding boundaries; AI never bypasses Suvoda's validated controls or reveals blinded treatment assignments.
Suvoda does not currently ship a native MCP server, but the platform exposes documented APIs that we wrap into a custom MCP server tailored to your data model and access policies. The Model Context Protocol is an open standard introduced by Anthropic for safely connecting AI assistants to data sources, and it has rapidly become the de facto contract for enterprise AI integration. By exposing Suvoda through MCP, you avoid model-specific lock-in — the same connection works with Claude Desktop, Claude Code, custom agents, and any future MCP-compatible client. The MCP layer is hosted on your infrastructure or in the IntuitionLabs AI proxy with full request logging.
The use cases that pay back fastest are: (1) drug supply forecasting — predicting site, depot, and country-level kit needs across the study with confidence intervals, reducing both stockouts and expensive overage; (2) protocol amendment impact analysis — turning a redlined protocol into a structured Suvoda study-build change request with effort estimates; (3) randomization and dispensation analytics — natural-language Q&A over IP movement, visit completion, and code break events; (4) operational alerting — early warning on enrollment-vs-forecast drift, expiry risk, and site supply imbalance; and (5) study-build assistance — drafting URS sections and configuration specs from approved protocols, with human review and sign-off.
Compliance comes from clear separation of AI roles. AI is used as a drafting and analysis aid; humans remain the responsible signatory under 21 CFR Part 11, EU Annex 11, and ICH E6(R3) GCP. Every AI-generated artefact passes through an explicit human review before it enters the Suvoda study build or any regulated downstream record. We log all prompts, model identifiers, model versions, retrieval sources, and responses to a tamper-evident audit store. This approach aligns with the principles in the FDA AI in drug development draft guidance and the EMA reflection paper on AI in the medicinal product lifecycle.
Blinding is a first-class concern in any AI integration with an IRT. We architect the MCP layer with explicit blinding boundaries — AI clients used by blinded teams see only blinded data, by construction, not by policy. Treatment assignment, code break history, and any other unblinded field is filtered at the MCP server before it ever reaches the model. We also enforce dual control on the small set of unblinded operational queries, log every tool call to a blinding-aware audit store, and run regression tests that confirm a blinded query path cannot leak unblinded fields. This aligns with ICH E6(R3) trial-integrity expectations.
We run AI in whichever deployment model fits your data residency and risk posture: cloud frontier models accessed via the IntuitionLabs AI proxy with no model-provider training on customer data, dedicated tenanted endpoints (Anthropic on AWS Bedrock, Azure OpenAI, GCP Vertex), or fully on-premise open-weight models running in your VPC. For trial-management data, sponsors usually want at least dedicated-tenant deployment with a contractual no-training guarantee; for higher-sensitivity workflows the on-premise path is available. We document the deployment topology, data flow diagrams, and DPIA-equivalent assessments so the security and quality functions can sign off cleanly.
A pilot covering a single high-value use case — for example, drug supply forecasting on an active oncology programme — typically goes from kickoff to production rollout in 8-12 weeks, including the validation work needed for the AI integration layer. A broader programme spanning forecasting, amendment impact analysis, and operational analytics takes 4-9 months and is best run as a series of validated releases. We start with the use case that has the clearest ROI signal — usually supply forecasting, where the dollar impact of avoided stockouts and reduced overage is straightforward to measure — and expand from there.
Traditional supply forecasting blends statistical models, planning spreadsheets, and clinical-supply judgement — and it routinely produces both expensive overage and unacceptable stockouts. AI-enhanced forecasting ingests Suvoda dispensation history, randomization probabilities, enrollment curves, kit expiry, visit-window flexibility, and depot lead times to produce site-, depot-, and country-level forecasts with confidence intervals. The model is refit continuously as the study runs and surfaces explicit confidence bands so supply planners know when to act. We validate the forecasting layer per GAMP 5 where it materially affects patient supply, with regression tests and continuous evaluation against actual outcomes.
Yes. Protocol amendments — particularly in oncology — are an operational drag because the impact on the Suvoda study build is rarely obvious from the redlined document alone. AI agents read the amended protocol, map changes to the existing Suvoda configuration (randomization schema, kit logic, visit schedules, eCOA forms), and produce a structured change request with effort estimates and risk flags. Clinical operations and validation teams then review and approve — the AI does not silently change the production study build. The pattern accelerates a recurring bottleneck without compromising change control aligned with ICH Q9(R1).
Operational analytics is where the most user-visible value lives. Instead of static dashboards, clinical operations teams ask natural-language questions — "which sites are at risk of stockout in the next 30 days?", "show me code break events this quarter and the time-to-resolution distribution", "what is the enrollment-vs-forecast variance by region?" The AI agent translates the question into a Suvoda API call or analytical query, returns a cited answer with the underlying data, and writes the query to the audit trail. Used in conjunction with Snowflake or Databricks data hubs, the same pattern extends to cross-study and cross-vendor analytics.
AI components are validated as configured items aligned with GAMP 5 Second Edition and FDA Computer Software Assurance principles. Each model and prompt is version-pinned; release to GxP environments goes through change control with regression test packs covering known prompts and expected outputs. We maintain a continuous evaluation harness that re-runs benchmark prompts on every model update and flags drift. Anthropic, OpenAI, and Google publish model cards and changelogs we incorporate into the periodic review evidence pack — see for example the Anthropic model release notes.
Operational cost is a function of usage pattern, model choice, and forecasting compute. For a typical sponsor running multiple active studies, monthly AI spend on supply forecasting, amendment analysis, and operational analytics lands in the low-to-mid five figures USD, dropping with retrieval caching and tiered routing of low-stakes queries to smaller, cheaper models. We architect AI services to make these levers explicit so AI cost-per-study trends down over time. Compared to a single avoided drug supply stockout in an active oncology trial, the ROI is typically positive within the first quarter of production use.
Ready to Layer AI on Your Suvoda Investment?
Ready to Layer AI on Your Suvoda Investment? image

Ready to Layer AI on Your Suvoda Investment?

Book a discovery session to scope a compliance-aware AI pilot on your Suvoda environment — designed for measurable supply forecasting accuracy, faster amendments, and inspection-ready audit trails.

Book a Meeting

© 2026 IntuitionLabs. All rights reserved.

Privacy PolicyTerms of ServiceBook Meeting